FULGENT GENETICS, INC. Total Contract Liability
FULGENT GENETICS, INC. (FLGT) had Total Contract Liability of $4.60 million as of 2019-03-31, per its 10-Q filed 2019-05-10.
Discontinued › Balance Sheet › Liabilities
us-gaap:ContractWithCustomerLiability · last filed 2019-05-10
- 2019-03-31: Contract with Customer, Liability $4.60M.
- 2018-12-31: Contract with Customer, Liability $5.90M.
| Period end | Contract with Customer, Liability |
|---|---|
| 2019-03-31 | $4.60M 10-Q · filed 2019-05-10 |
| 2018-12-31 | $5.90M 10-Q · filed 2019-05-10 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| BIODESIX INC (BDSX) | United States | $0.312B | |
| Lumexa Imaging Holdings, Inc. (LMRI) | United States | $0.951B | |
| EXAGEN INC. (XGN) | United States | $0.212B | -5.95 |
| Freenome, Inc. (FRNM) | United States | $0.143B | |
| CASTLE BIOSCIENCES INC (CSTL) | United States | $1.074B | -37.45 |
| SERA PROGNOSTICS, INC. (SERA) | United States | $0.062B | -5.75 |
| AMERICAN SHARED HOSPITAL SERVICES (AMS) | United States | $0.010B | -5.64 |
| Advanced Biomed Inc. (ADVB) | $0.009B | ||
| Aclarion, Inc. (ACON) | United States | $0.008B | |
| BioNexus Gene Lab Corp (BGLC) | $0.004B |